|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| REVENUES | |||||
| Policy charges and fee income | |||||
| Premiums | |||||
| Net derivative gains (losses) | |||||
| Net investment income (loss) | |||||
| Investment gains (losses), net: | |||||
| Credit and intent to sell losses on available-for-sale debt securities and loans | |||||
| Other investment gains (losses), net | |||||
| Total investment gains (losses), net | |||||
| Investment management and service fees | |||||
| Other income | |||||
| Total revenues | |||||
| BENEFITS AND OTHER DEDUCTIONS | |||||
| Policyholders’ benefits | |||||
| Remeasurement of liability for future policy benefits | |||||
| Change in market risk benefits and purchased market risk benefits | |||||
| Interest credited to policyholders’ account balances | |||||
| Compensation and benefits | |||||
| Commissions and distribution-related payments | |||||
| Interest expense | |||||
| Amortization of deferred policy acquisition costs | |||||
| Other operating costs and expenses | |||||
| Total benefits and other deductions | |||||
| Income (loss) from continuing operations, before income taxes | |||||
| Income tax (expense) benefit | |||||
| Net income (loss) | |||||
| Less: Net income (loss) attributable to the noncontrolling interest | |||||
| Net income (loss) attributable to Holdings | |||||
| Less: Preferred stock dividends | |||||
| Net income (loss) available to Holdings’ common shareholders, basic | |||||
| Net income (loss) available to Holdings’ common shareholders, diluted | |||||
| EARNINGS PER COMMON SHARE | |||||
| Net income (loss) applicable to Holdings’ common shareholders per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average common shares outstanding (in millions): | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...